Rep. Robert Bresnahan, Jr. Purchases Shares of Revvity, Inc. (NYSE:RVTY)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Revvity, Inc. NYSE: RVTY. In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on February 25th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
• Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
• Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
• Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
• Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
• Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.

Revvity Price Performance

Revvity stock traded up $1.94 during mid-day trading on Wednesday, reaching $106.25. 335,103 shares of the company's stock traded hands, compared to its average volume of 948,726. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The company has a market cap of $12.77 billion, a price-to-earnings ratio of 48.08, a PEG ratio of 3.82 and a beta of 1.06. The stock has a 50 day moving average of $114.52 and a two-hundred day moving average of $116.91. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41.

Remove Ads

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the business earned $1.25 EPS. Equities analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.26%. The ex-dividend date is Thursday, April 17th. Revvity's dividend payout ratio is presently 12.67%.

Hedge Funds Weigh In On Revvity

Several institutional investors and hedge funds have recently bought and sold shares of the company. Victory Capital Management Inc. boosted its position in shares of Revvity by 17.4% in the 4th quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock worth $7,841,000 after purchasing an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Revvity by 13.7% in the third quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after buying an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. boosted its holdings in Revvity by 1,715.9% in the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock worth $7,722,000 after acquiring an additional 65,376 shares in the last quarter. FMR LLC grew its stake in shares of Revvity by 40.8% during the third quarter. FMR LLC now owns 155,556 shares of the company's stock worth $19,872,000 after acquiring an additional 45,040 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its holdings in shares of Revvity by 87.0% during the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after acquiring an additional 3,672 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Revvity

In other news, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the firm's stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company's stock, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Barclays raised their price target on Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. KeyCorp raised their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Bank of America upgraded shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 target price on the stock in a report on Friday, December 13th. Raymond James reaffirmed an "outperform" rating and issued a $145.00 price target (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Finally, Sanford C. Bernstein lowered shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $136.25.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.